Latest Post

Synopsis : Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today reported further positive Phase 2 data for their Lyme disease vaccine …

Summary : Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total …

Summary : Targa Resources Corp. (NYSE: TRGP) (“Targa” or the “Company”) announced today that it has executed agreements selling its wholly-owned subsidiary that holds a 25 percent equity interest in …

Summary : OceanFirst Financial Corp. (NASDAQ:”OCFC”), (the “Company”), the holding company for OceanFirst Bank N.A. (the “Bank”), today, announced the Company has signed an agreement to acquire a majority interest in …

Summary : -As Australians gear up for the further reopening of international travel lanes in 2022, proof of COVID-19 vaccination is a necessity. -To provide this proof, Verizon Business Australia …

Global Crossing Airlines Group, Inc. (JET: TSX-V; JET.B: TSX-V; JETMF: OTCQB) (the “Company” or “GlobalX”) today announces that, on February 3, 2022 the Company filed a Form 8-A Registration Statement (“Form …

Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated commercially with Libmeldy in Germany and France A …

Summary : On Thursday, Mersana Therapeutics signed a research and licensing deal with Janssen Biotech to access each other’s proprietary technology in discovering new antibody-drug conjugates (ADCs) for three cancer …

Synopsis : A $1.5 billion diabetes partnership between Eli Lilly and China-based Regor Therapeutics Group is at the center of a lawsuit filed by Pfizer, claiming that the founders of …

Synopsis : A new study published in the journal Nature found that two patients with leukemia who were treated with CAR T-cell therapy are still in remission 10 years later. …

Summary : Featuring nine of the most important regions in the life sciences industry, BioSpace’s Hotbed Maps are the guide employees and investors across the sector look to in order …

Summary : Amgen (NASDAQ:AMGN) and Plexium, Inc. (Plexium) today announced an exclusive, worldwide, multi-year research collaboration and license agreement to identify novel targeted protein degradation therapeutics toward historically challenging drug …

Summary :  A new option for those affected by keratoconjunctivitis sicca. The FDA approved the first generic of cyclosporine ophthalmic emulsion (Restasis) for dry eye, a condition that affects millions …

Summary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute involving the human immunodeficiency virus (HIV) drug dolutegravir. …

Synopsis : A powerful class of antibiotics called carbapenems can circumvent antibiotic resistance thanks to a particular chain of atoms in their structure. Now, a team of researchers from Penn …

Summary : Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional …

A highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among the vaccinated thanks to its ability to evade …

Synopsis : The Budget had reduced cooperatives’ alternate minimum tax and charge. Meenesh Shah, Chairman, National Dairy Development Board had welcomed the reduction in alternate minimum tax for cooperative from …

Synopsis : The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in …

Summary : Budget 2022 India Live, FM Nirmala Sitharaman Speech Live Updates: Speaking at a press conference after presenting the Union Budget, Finance Minister Nirmala Sitharaman said a conscious decision …

The prior authorization process often involves complex transactions and increases the burden not only on physicians and pharmacies, but can also impact patient access. Drug pricing and reimbursement is a …

Summary : In a clinical trial, the median annualized bleeding rates for all bleeds was reduced from a historical median of 5 to an on-study median of 2.3, which is …

Synopsis : ViiV Healthcare’s HIV treatment Cabenuva has been approved by the U.S. Food and Drug Administration for use every two months, meaning patients only have to receive an injectable …

Synopsis :: -ImmunityBio shared positive results from the clinical trial of its IL-15 superagonist Anktiva (N-803) to treat people living with human immunodeficiency virus (HIV). -The Phase I HIV Cure …

Summary : Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in FY21; Adar Poonawalla holds 8.6% stake …

Synopsis : Autonomous vehicle industry veteran will build on early success to lead operational growth, oversee geographic expansion, and spearhead Embark’s commercialization effort. Embark Trucks, Inc. (Nasdaq: EMBK, “Embark”), a …

Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe hypertriglyceridemia (SHTG), or high triglycerides. Pfizer was leading …

Synopsis : Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases, announced today that Dr. Dominic F. Labriola has joined Madrigal as Senior Vice President …

Synopsis : Shares of Madrigal Pharmaceuticals went up in premarket trading after the company announced positive topline data from its Phase III assessment of resmetirom in non-alcoholic fatty liver disease. …

Summary : One week after Johnna Rossell departed Biogen for Enzyvant, the embattled company announced that two members of its board of directors are leaving. Nancy Leaming and Brian Posner …

Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax …

Summary : Merck & Co Inc and partner Ridgeback Biotherapeutics said on Friday six lab studies showed their experimental oral COVID-19 drug molnupiravir was active against the fast-spreading Omicron variant. The …

Synopsis : Granules India Ltd on Thursday said it has received approval from the US health regulator for its generic Amphetamine mixed salts indicated for the treatment of Attention Deficit …

Summary : String Bio, a Bengaluru-based company, has developed a platform for converting methane into various solutions such as biostimulants for crops, animal feed, and alternative protein for human consumption …

Summary : Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”) a leader in enabling personalized medicine, announced today that it was terminating its previously announced rights offering and the …

Synopsis : Biogen is selling its nearly 50% stake in South Korea-based Samsung Bioepis for $2.3 billion. The move will provide Biogen with additional capital while preparing to cut additional …

  Courtesy of Alzamend Neuro On the strength of data from its Phase 1 Study  of lead compound, AL001, being developed for the treatment of Alzheimer’s disease, Alzamend Neuro is looking …

Summary : Oxford Biomedica and Homology Medicines to establish Oxford Biomedica Solutions LLC, a new U.S.-based AAV Manufacturing and Innovation Business Homology Medicines to receive $130 million from Oxford Biomedica …

Executive Summary The pharma also warns that an FDA complete response letter could be coming for its supplemental NDA to add atopic dermatitis to the JAK1 inhibitor’s label. Olumiant’s list …

Summary : The first doses of an experimental HIV vaccine have been delivered in a phase 1 clinical trial. International AIDS Vaccine Initiative (IAVI), a non-profit scientific research organisation – …

Summay : EAMS scientific opinion issued to Global Blood Therapeutics (UK) Ltd for Voxelotor in the treatment of hemolytic anemia in patients with sickle cell disease. MHRA awards a positive …

Highlight : The Clalit Research Institute, in collaboration with researchers from Harvard University and Tel-Aviv University, analyzed one of the world’s largest integrated health record databases to examine the indirect …

Summary : A high-level delegation from Colombia led by Marta Lucia Ramirez de Rincn, Vice-President and Minister of Foreign Affairs, visited Department of Biotechnology. India and Colombia exchanged views on …

Summary : Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal gel, in the American market. The drug firm …

Summary : Union Minister for Chemicals and Fertilizers  Mansukh Mandaviya today launched NIPER Research Portal along with Shri Bhagwanth Khuba, Minister of State for Chemicals and Fertilizers in presence of …

Synopsis : Dr Reddy’s Laboratories on Friday said it is in discussions with the Indian drug regulator to bring Russia’s Sputnik M, a COVID-19 vaccine for the 12 to18-year-old category, …

Synopsis : Vaccine maker Bharat Biotech said that its nasal Covid-19 vaccine has been approved by the drug regulator for phase 3 clinical trials in the country. An intra-nasal vaccine …

Synopsis : The new so-called variant being talked about right now has been dubbed and was originally found in a population of bats from South Africa. To date, NeoCoV is …

Synopsis : The 2022 Alltech Agri-Food Outlook was released recently highlighting global feed production survey data. The global COVID-19 pandemic has had major impacts on the agri-food sector, contributing to …

Summary : Arun Misra, CEO of Hindustan Zinc, has been elected as the next Chairman of the International Zinc Association (IZA). Misra is the first Indian and Asian to hold the role of …